UnitedHealth Group Inc. (UNH) Financials Nov 20, 2014, 5:13
UnitedHealth Group Inc. (UNH) Financials Nov 20, 2014, 5:13 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for UnitedHealth Group Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 87.2B 94.18B 101.87B 110.62B 122.5B
Premiums Earned 79.32B 85.41B 91.98B 99.73B 109.56B
Total Investment Income 581M 538M 541M 524M 564M
Realized Gains (Losses) 75M 94M 125M 162M 189M
Other Operating Income 7.23B 8.14B 9.23B 10.21B 12.19B
Losses, Claims & Reserves 65.29B 68.84B 74.33B 80.23B 89.29B
Losses, Benefits & Adjustments 65.29B 68.84B 74.33B 80.23B 89.29B
2009 2010 2011 2012 2013 5-year trend
Selling, General & Admin. Expenses & Other 15.49B 17.45B 19.07B 21.14B 23.58B
Selling, General & Admin. Expenses 13.73B 15.33B 16.68B 18.62B 20.74B
Other Selling, General & Admin. Expense 13.73B 15.33B 16.68B 18.62B 20.74B
Underwriting & Commissions - - - - -
Other Operating Expense 1.77B 2.12B 2.39B 2.52B 2.84B
Operating Income Before Interest Expense 6.42B 7.89B 8.48B 9.26B 9.63B
Interest Expense, Net of Interest Capitalized 551M 481M 505M 632M 708M
Interest Expense (excl. Interest Capitalized) 551M 481M 505M 632M 708M
Interest Capitalized - - 0 0 0
Operating Income After Interest Expense 5.87B 7.41B 7.97B 8.63B 8.92B
Non-Operating Income (Expense) 0 0 0 0 0
Miscellaneous Non Operating Expense 0 0 0 0 0
Equity in Affiliates (Pretax) - 0 0 - -
Unusual Expense 64M 23M 12M 6M 8M
Pretax Income 5.81B 7.38B 7.96B 8.62B 8.92B
Income Taxes 1.99B 2.75B 2.82B 3.1B 3.24B
Income Tax - Current - Domestic 2B 2.7B 2.76B 2.79B 3.24B
Income Tax - Current - Foreign - - - - -
Income Tax - Deferred - Domestic (16M) 45M 59M 308M 1M
Income Tax - Deferred - Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 3.82B 4.63B 5.14B 5.53B 5.67B
Minority Interest Expense 0 0 0 0 48M
Net Income 3.82B 4.63B 5.14B 5.53B 5.63B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 3.82B 4.63B 5.14B 5.53B 5.63B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 3.82B 4.63B 5.14B 5.53B 5.63B
EPS (Basic) 3.27 4.14 4.81 5.38 5.59
Basic Shares Outstanding 1.17B 1.12B 1.07B 1.03B 1.01B
EPS (Diluted) 3.24 4.10 4.73 5.28 5.50
Diluted Shares Outstanding 1.18B 1.13B 1.09B 1.05B 1.02B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...
Continue Reading
Quantum Leap: Chattanooga's Bold Move So Chattanooga’s making waves again, folks. EPB just unveiled its new big shot, the IonQ Forte Enterprise quantum computer. That's right, they’ve slapped a commercial quantum computer and a networking hub together, right here in this Tennessee city. Is this a tech haven or what? Not to mention, it’s the first in America. A New...
Continue Reading
Sunglasses Designed for Every Face Type When it comes to picking the right pair of shades, face shape is only part of the equation. Expert Consumers just dropped their 2026 verdict, spotlighting Quay as the go-to brand for those wider faces, tricky nose bridges, and the noggins that run a tad larger than average. Forget what you heard about one-size-fits-all. This...
Continue Reading
The Sky's Not the Limit—It's Just the Beginning Step aside, conventional paths. There's a flight school owner in Sedona, Arizona, making waves by encouraging girls to swap their land-bound dreams for sky-high aspirations. This International Girls in Aviation Day, Michelle Smith wants young dreamers to know their possibilities span as wide as the open sky. Defying...
Continue Reading
Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...
Continue Reading
Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...
Continue Reading
Mental Health Steals the October Spotlight In the bustling streets of New York City, October is about to get a mental health makeover. Project Healthy Minds is putting the pedal to the metal with their fourth annual World Mental Health Day Gala on October 8th, followed by the world’s largest mental health festival on October 10th. These events, held at Spring Studios,...
Continue Reading
Radon Mitigation: A Critical Measure for Home Safety Homeowners, you're probably aware of the ticking health time bomb known as radon. Not just an annoying gas, this colorless, odorless beast lurks quietly, threatening family health if not managed right. Mitch Kelley, a specialist in radon testing with Basement Solutions in Mankato, Minnesota, lays out a no-fuss guide to...
Continue Reading
Chery Auto Puts Eco Tech at Front and Center You know, Chery Auto isn't just manufacturing cars anymore—it's shaping an entire lifestyle. For the uninitiated, they’re calling in everyone worth knowing to their headquarters in Wuhu, China, come October 18 through 24. The 2026 Chery International User Summit is kind of a big deal this year with nearly 20 new green...
Continue Reading
AI's Increasing Role: A Double-Edged Sword for Leaders Hey, the tech overlords remind us once again—the future doesn't wait for anyone to catch up before it bulldozes forward. Info-Tech Research Group has sounded the alarm on AI agents muscling their way into product decisions without any clear nod from the human corner office. Blurring Lines of Accountability The...
Continue Reading
Top 5 Most Recently Viewed Articles
Credit card debt became a mounting problem for many consumers, hitting a staggering $1.14 trillion recently. This hefty figure marked an alarming increase of $27 billion in just one quarter—definitely not the kind of trend any trader or financial guru wants to see. Traders were buzzing about this spike back then, grappling with what it meant for consumer spending and...
Continue Reading
Tachyus Partners with Anschutz Exploration Tachyus has announced an exciting collaboration with Anschutz Exploration to implement Aurion, its innovative platform designed for efficient greenhouse gas (GHG) emissions management. This contract marks a significant step for Anschutz, aiming to establish a comprehensive GHG baseline while effectively monitoring and forecasting...
Continue Reading
Sampo plc's Share Buyback Program: An Overview Sampo plc has made significant strides in its share buyback initiatives. As shareholders, it is essential to stay updated on how these developments may affect your investments. Recently, the company disclosed its activities regarding A share repurchases, which offer insights into its strategic approach in the market. Details...
Continue Reading
Overview of CRENESSITY™ Approval Neurocrine Biosciences, Inc. announced a significant breakthrough with the FDA's approval of CRENESSITY™ (crinecerfont), marking the first new treatment for classic congenital adrenal hyperplasia (CAH) in nearly seven decades. This innovative therapy represents a profound shift in the management of this serious genetic condition that...
Continue Reading
Exciting Clinical Results for NX-5948 In a noteworthy development, Nurix Therapeutics, Inc. has shared promising results from their ongoing Phase 1a/1b clinical trial of NX-5948, aimed at treating patients with relapsed or refractory Waldenstrom's macroglobulinemia (WM). In this trial, NX-5948, a targeted degrader of Burton's tyrosine kinase (BTK), demonstrated...
Continue Reading